Azenta Life Sciences Names Matthew McManus Chief Operating Officer

CHELMSFORD, Mass., Jan. 6, 2022 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) today announced that it has appointed Matthew McManus Chief Operating Officer effective January 17th.  In this newly created role, Dr. McManus will oversee Life Sciences Products, Services, and all commercial operations of the business and will report directly to the CEO. “We are excited to have Matt join the Company... Read more

Azenta Life Sciences Expands Fleet of PacBio HiFi Sequencing Systems

MENLO PARK, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) — PacBio (Nasdaq: PACB) today announced an expansion of its extensive suite of HiFi applications with Azenta Life Sciences, formerly GENEWIZ. The deal will increase PacBio’s HiFi sequencing platforms across Azenta’s newly combined company and support Azenta’s mission to enable life science companies to deliver impactful breakthroughs... Read more

JEOL Introduces New Scanning Electron Microscope with “Simple SEM” Automation and Live Elemental and 3D Analysis

A new Scanning Electron Microscope (SEM) from JEOL answers the need for faster and easier acquisition of both SEM images and EDS data analysis, especially suited for repetitive operations and quality control. JEOL, the global leader in the development of cutting-edge Electron Microscopes for materials characterization and analysis, introduces its latest SEM, the JSM-IT510. This... Read more

PacBio and Care4Rare Consortium Collaborate on Rare Disease Research Study

MENLO PARK, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) — PacBio, a leading provider of high-quality, long-read sequencing platforms, and the Care4Rare Canada Consortium (Care4Rare) announce today they are collaborating to study some of the most complex unexplained rare disease cases within Canada. Care4Rare, led out of the CHEO Research Institute affiliated with the University of Ottawa,... Read more

Thermo Fisher Scientific Completes Acquisition of PeproTech, a Leader in Recombinant Proteins

Thermo Fisher Scientific Completes Acquisition of PeproTech, a Leader in Recombinant Proteins WALTHAM, Mass., Jan. 5, 2022 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and PeproTech, Inc., a leading developer and manufacturer of recombinant proteins, today announced that Thermo Fisher completed its acquisition of PeproTech on December 30, 2021 for a total cash... Read more

GE Healthcare announces collaboration with Boston Scientific in Southeast Asia to offer end-to-end interventional cardiac care portfolio

Full spectrum of innovative solutions empowers better heart care and builds efficiency across the care pathway SINGAPORE — 5 Jan 2022: GE Healthcare announced a collaboration with Boston Scientific to provide a comprehensive solution offering, from diagnostic to percutaneous coronary intervention (PCI) to cardiac care centers in Southeast Asia, which also means easier access to... Read more

Using Zebrafish to Understand How Blood and Lymphatic Vessels Develop

The above image displaying ribosomal biogenesis and blood vessels in developing zebrafish embryos was awarded first prize in the life sciences category of the LMA/VIA 2021 Image Competition (sponsored by ZEISS) of the Australian Microscopy & Microanalysis Society. Dr. Kazuhide Shaun Okuda, Postdoctoral Fellow at the Hogan laboratory, Peter MacCallum Cancer Centre in Victoria, Australia, took... Read more

PacBio to Present at Upcoming Investor Conference

MENLO PARK, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) — PacBio announced today that its executives will be speaking virtually at the following investor conference: 40th Annual J.P. Morgan Healthcare Conference on January 13, 2022, at 12:00 pm Eastern Time (9:00 am Pacific Time) The live webcast can be accessed at the company’s investors page at... Read more